Can we increase male involvement in AIDS treatment?

The Lancet

Volumn 376, Issue 9749, 2010, Pages 1302-

  Birungi, Josephine ^a   Mills, Edward J ^b  

^a THE AIDS SUPPORT ORGANIZATION   (Uganda)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MALE; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; PATIENT ADVOCACY; PRIORITY JOURNAL; SEX DIFFERENCE; DEVELOPING COUNTRY; HIV INFECTIONS; PSYCHOLOGY; UGANDA;

DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; MALE; MEN; UGANDA;

EID: 77958106229     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61918-6     Document Type: Letter

References (5)

1. M May, A Boulle, S Phiri Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes Lancet 376 2010 449 457
2. P Braitstein, A Boulle, D Nash Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration J Womens Health 17 2008 47 55
3. AS Muula, TJ Ngulube, S Siziya Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review BMC Public Health 7 2007 63
4. A Greig, D Peacock, R Jewkes, S Msimang Gender and AIDS: time to act AIDS 22 suppl 2 2008 S35 S43
5. Bakanda C, Birungi J, Mwesigwa R, et al. Rates of mortality by baseline CD4 cell count after initiating antiretroviral therapy among Ugandan HIV+ patients. Presented at the XVIII International AIDS Conference; Vienna, Austria; July 18-23, 2010.